Clinical Trials Logo

Clinical Trial Summary

This study was designed to evaluate consistency in the antibody response to three manufactured lots of an investigational Rotavirus Vaccine.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT00092456
Study type Interventional
Source Merck Sharp & Dohme Corp.
Contact
Status Completed
Phase Phase 3
Start date May 2003
Completion date August 2004

See also
  Status Clinical Trial Phase
Completed NCT02538211 - The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses N/A
Completed NCT02220439 - Does the Fecal Microbiome Influence Rotarix Immunogenicity N/A
Withdrawn NCT00757926 - Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants Phase 1/Phase 2
Not yet recruiting NCT00484952 - Surveillance of Hospitalizations Due to Rotavirus Infections Among Children From Israel N/A
Completed NCT00092443 - Dose Confirmation Efficacy Study (V260-007) Phase 3
Terminated NCT01357174 - ROTATEQ™ Post-Marketing Surveillance in the Philippines N/A
Recruiting NCT01363726 - Surveillance of Rotavirus Gastroenteritis in Children <5 Years N/A
Completed NCT00130832 - Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED) Phase 3
Recruiting NCT06080906 - Phase II Clinical Trial of the Inactivated Rotavirus Vaccine Phase 2
Recruiting NCT03313128 - SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance
Completed NCT02542462 - Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study Phase 4
Completed NCT00346892 - To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV Phase 2
Not yet recruiting NCT05212935 - A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region, Italy
Completed NCT00981669 - Rotavirus Vaccine Produced by Butantan Institute Phase 1
Completed NCT05037435 - Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years. Phase 3
Completed NCT03483116 - A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine Phase 2
Completed NCT03870061 - Evaluation of an Infant Immunization Encouragement Program in Nigeria N/A
Active, not recruiting NCT05621655 - Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers Phase 2
Completed NCT00280111 - Safety and Immunogenicity Study of Live Attenuated Indian Rotavirus Vaccine Candidate Strains 116E and I321 in Infants Phase 1
Completed NCT00090233 - Rotavirus Efficacy and Safety Trial (REST)(V260-006) Phase 3